Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 870,300 | 825,400 | 666,600 | 119,600 | 87,200 |
| Marketable Securities | 782,800 | 1,063,700 | 989,300 | 1,588,600 | 918,000 |
| Receivables | 1,377,200 | 1,233,500 | 1,167,200 | 1,184,400 | 977,600 |
| Inventories | 1,142,600 | 1,080,500 | 1,089,400 | 1,028,200 | 889,200 |
| Other current assets | 263,000 | 301,700 | 182,300 | 179,900 | 91,200 |
| TOTAL | $4,435,900 | $4,504,800 | $4,094,800 | $4,100,700 | $2,963,200 |
| Non-Current Assets | |||||
| PPE Net | 2,109,800 | 1,784,100 | 1,655,100 | 1,505,900 | 1,351,300 |
| Investments And Advances | 1,422,700 | 1,103,300 | 1,036,500 | 732,300 | 1,072,600 |
| Other Non-Current Assets | 1,083,600 | 932,600 | 851,200 | 583,700 | 399,900 |
| TOTAL | $4,616,100 | $3,820,000 | $3,542,800 | $2,821,900 | $2,823,800 |
| Total Assets | $9,052,000 | $8,324,800 | $7,637,600 | $6,922,600 | $5,227,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 450,300 | 401,400 | 359,700 | 357,000 | 307,200 |
| Accrued Expenses | 283,600 | 236,500 | 207,900 | 213,400 | 153,700 |
| Other current liabilities | 576,000 | 479,200 | 548,700 | 460,400 | 251,800 |
| TOTAL | $3,116,900 | $2,911,600 | $2,344,300 | $1,956,600 | $1,234,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 193,300 | 190,600 | 226,900 | 248,900 | 285,400 |
| Other Non-Current Liabilities | 156,700 | 136,100 | 113,400 | 104,900 | 88,900 |
| TOTAL | $843,100 | $877,400 | $992,200 | $1,083,600 | $577,900 |
| Total Liabilities | $3,960,000 | $3,789,000 | $356,500 | $3,018,000 | $1,790,400 |
| Shareholders' Equity | |||||
| Common Shares | 16,500 | 16,500 | 16,500 | 16,500 | 16,500 |
| Retained earnings | 4,509,900 | 4,105,400 | 3,697,400 | 3,327,100 | 2,933,700 |
| Other shareholders' equity | 256,000 | 47,400 | 145,200 | 125,700 | -18,600 |
| TOTAL | $5,092,000 | $4,535,800 | $4,301,100 | $3,882,400 | $3,415,200 |
| Total Liabilities And Equity | $9,052,000 | $8,324,800 | $4,657,600 | $6,900,400 | $5,205,600 |